ADAMTS4与人类颈动脉粥样硬化斑块易损性的关系
研究纳入48例颈动脉狭窄行颈动脉内膜切除术患者的斑块标本,按AHA标准分为稳定组与易损组。易损组斑块ADAMTS4表达及血清浓度显著高于稳定组,versican表达更低;
要点
- 易损组斑块ADAMTS4表达及血清浓度均显著高于稳定组。
- 易损组versican表达显著低于稳定组。
- ADAMTS4为斑块易损性的独立危险因素(OR 1.14)。
核心结论
- ADAMTS4在颈动脉粥样硬化斑块发展中表达上调,其血清水平与斑块易损性增加相关,可能是斑块易损性的潜在生物标志物。
研究设计与样本
- 研究获取48例因颈动脉狭窄行颈动脉内膜切除术患者的48份颈动脉粥样硬化斑块标本,行HE和Movat五色染色、ADAMTS4/versican/巨噬细胞免疫组化及血清ADAMTS4检测,按AHA分类标准分为稳定组与易损组比较。
临床怎么用
- 血清ADAMTS4可能作为评估颈动脉斑块易损性的潜在生物标志物,用于辅助识别高危颈动脉狭窄患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rupture of atherosclerotic plaques and the resulting thrombosis are vital causes of clinical ischemic events. Recent studies have shown that ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs 4) is a pathogenic factor of plaque vulnerability in mice. However, the relationship between ADAMTS4 and carotid atherosclerotic vulnerable plaques in humans remains unclear. METHODS: Forty-eight carotid atherosclerotic plaque specimens were obtained from 48 carotid artery stenosis inpatients undergoing carotid endarterectomy. We performed hematoxylin and eosin and Movat pentachrome staining for histologic characteristics; immunohistochemical staining for ADAMTS4, versican, and macrophages; and serologic tests for ADAMTS4. Patients were divided into stable and vulnerable groups on the basis of histologic characterization according to the classification criteria of the American Heart Association. Comparison between the groups was carried out using SPSS 17.0 (SPSS Inc, Chicago, Ill). RESULTS: Expression of ADAMTS4 in the plaque and its serum concentration were significantly higher in the vulnerable group compared with the stable one (P = .004 and P = .021, respectively), whereas the expression of versican was lower in the vulnerable group than in the stable group (P = .015). Univariate analysis revealed that the incidence of symptomatic cerebral ischemic events and ADAMTS4 serum levels were statistically higher in the vulnerable group compared with the stable group (P = .021 and P = .029, respectively). Multivariate analysis showed that ADAMTS4 was an independent risk factor (odds ratio, 1.14; P = .038). CONCLUSIONS: Our study revealed that ADAMTS4 expression was upregulated during carotid atherosclerotic plaque development. Serum levels of ADAMTS4 were associated with increased plaque vulnerability in both symptomatic and asymptomatic patients with carotid artery stenosis. ADAMTS4 may be a potential biomarker for plaque vulnerability.
引用
- Dong H, Du T, Premaratne S, et al. Relationship between ADAMTS4 and carotid atherosclerotic plaque vulnerability in humans. J Vasc Surg. 2017. PMID: 29153440. doi:10.1016/j.jvs.2017.08.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。